Might also be some short covering in to year end. In October all of my holdings were lent out, in late October and early November there had been significant covering but about 25% of my shares have remained on borrow. Or maybe we will get a positive Aducanumab decision overnight, although I would have expected Eisai would also have moved if that were the case.
Putting numbers on it, page-47
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.0¢ |
Change
-0.040(4.26%) |
Mkt cap ! $155.3M | |||
| Open | High | Low | Value | Volume |
| 91.0¢ | 91.5¢ | 89.5¢ | $13.66K | 15.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8443 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 4762 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| CGS (ASX) Chart |